Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

977 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Management of glucocorticoid-induced osteoporosis.
Rizzoli R, Adachi JD, Cooper C, Dere W, Devogelaer JP, Diez-Perez A, Kanis JA, Laslop A, Mitlak B, Papapoulos S, Ralston S, Reiter S, Werhya G, Reginster JY. Rizzoli R, et al. Among authors: reginster jy. Calcif Tissue Int. 2012 Oct;91(4):225-43. doi: 10.1007/s00223-012-9630-5. Epub 2012 Aug 10. Calcif Tissue Int. 2012. PMID: 22878667 Review.
Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group.
McClung MR, Geusens P, Miller PD, Zippel H, Bensen WG, Roux C, Adami S, Fogelman I, Diamond T, Eastell R, Meunier PJ, Reginster JY; Hip Intervention Program Study Group. McClung MR, et al. Among authors: reginster jy. N Engl J Med. 2001 Feb 1;344(5):333-40. doi: 10.1056/NEJM200102013440503. N Engl J Med. 2001. PMID: 11172164 Free article. Clinical Trial.
[Postmenopausal osteoporosis in women].
Reginster JY, Devogelaer JP, Kaufman JM, Appelboom T, Vanhaelst L. Reginster JY, et al. Rev Med Liege. 1999 Apr;54(4):335-40. Rev Med Liege. 1999. PMID: 10389480 Free article. French.
Prevention of postmenopausal bone loss by tiludronate.
Reginster JY, Lecart MP, Deroisy R, Sarlet N, Denis D, Ethgen D, Collette J, Franchimont P. Reginster JY, et al. Lancet. 1989 Dec 23-30;2(8678-8679):1469-71. doi: 10.1016/s0140-6736(89)92927-9. Lancet. 1989. PMID: 2574764 Clinical Trial.
Effect of raloxifene combined with monofluorophosphate as compared with monofluorophosphate alone in postmenopausal women with low bone mass: a randomized, controlled trial.
Reginster JY, Felsenberg D, Pavo I, Stepan J, Payer J, Resch H, Glüer CC, Mühlenbacher D, Quail D, Schmitt H, Nickelsen T. Reginster JY, et al. Osteoporos Int. 2003 Sep;14(9):741-9. doi: 10.1007/s00198-003-1432-1. Epub 2003 Jun 19. Osteoporos Int. 2003. PMID: 12827224 Clinical Trial.
977 results